Brief: Medigene Announces Positive Final 2-Year Topline Data In DC Vaccine Phase I/II Trial In AML Patients

Medigene AG

10/01/2020 13:22

Jan 10 (Reuters) - MEDIGENE AG  MDG1k.DE :
    * POSITIVE FINAL 2-YEAR TOPLINE DATA IN COMPLETED DC VACCINE
PHASE
I/II TRIAL IN AML PATIENTS
    * DC VACCINATIONS WERE WELL TOLERATED WITH NO SERIOUS
ADVERSE
EVENTS (SAES) RELATED TO TREATMENT
    * PRIMARY OUTCOME MEASURES WERE SUCCESSFULLY ACHIEVED

Source text for Eikon:  ID:nPexdfs4qa 
Further company coverage:  MDG1k.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))